SNSE
Faeth Therapeutics, Inc. · HEALTHCARE
Cambrian Biopharma Inc sold $55K of Faeth Therapeutics, Inc.
10% owner
Sold$54,575
$8.25Price
6,612Shares
−4%Stake
What SNSE did after the filing
- The stock from Thu, Dec 11 open, $8.06
- +23.3%
- S&P 500, same days
- +2.4%
Measured over 30 trading days, to the Jan 27 close.
Traded Tue, Dec 9. Filed Wed, Dec 10, 4:56 PM ET, after the close. Returns use the Dec 11 open and the Jan 27 close. Not investment advice.